Daunorubicin citrate

Cat. No.: IBDI-437862

Daunorubicin (Daunomycin) citrate is a topoisomerase II inhibitor with potent anti-tumor activity. Daunorubicin citrate inhibits DNA and RNA synthesis. Daunorubicin citrate is a cytotoxin that inhibits cancer cell viability and induces apoptosis and necrosis. Daunorubicin citrate is also an anthracycline antibiotic. Daunorubicin citrate can be used in the research of infection and variety of cancers, including leukemia, non-Hodgkin lymphomas, Ewing's sarcoma, Wilms' tumor.

Product Details

Target	TopoisomeRase | DNA/RNA Synthesis | ADC Cytotoxin | Autophagy | Bacterial | Antibiotic | Apoptosis
Molecular Weight	719.64
Synonyms	Daunomycin(citrate), RP 13057(citrate), Rubidomycin(citrate
SMILES	OC(C(O)=O)(CC(O)=O)CC(O)=O.OC1=C2C([[email protected]](C[[email protected]@](C(C)=O)(O)C2)O[[email protected]@]3([H])C[[email protected]@H]([[email protected]](O)[[email protected]](C)O3)N)=C(O)C4=C1C(C5=CC=CC(OC)=C5C4=O)=O

Storage & Handling

Shipping	Room temperature in continental US. May vary elsewhere.
Storage	Please store the product under the recommended conditions in the Certificate of Analysis.
Regulatory Status	This product is for RESEARCH USE ONLY and is not intended for therapeutic or diagnostic use.